SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer☆
Publication date: October 2026 Source: Annals of Oncology, Volume 37, Issue 10 Author(s): A.C. Garrido-Castro, S.E. Kim, T. Li, J. Desrosiers, R. Nanda, Y. Abdou, A.S. Clark, R.L. Sacks, T. O’Connor, N. Sinclair, S. Lo, G. Augdahl, E. Wrabel, M. DiLullo, T. Rahman, A. Patel, M.E. Hughes, J. Baginska, P.B. Lange, T. O’Meara
SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer☆. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426009609?dgcid=rss_sd_all
SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer☆. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426009609?dgcid=rss_sd_all
“SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer☆.” Annals of Oncology.
@article{article88408,
title = {SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer☆},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426009609?dgcid=rss_sd_all}
}
ABSTRACT Diagnosing and classifying platelet disorders (PD) is challenging in children. Therefore, we evaluated clinical, laboratory, and genetic data to improve current algorithms by performing a prospective observational cohort study...
Abstract Background and Objectives Perioperative blood transfusion in hip arthroplasty is associated with increased morbidity, prolonged hospitalization, and higher costs. This study aimed to identify independent risk factors and...